Preclinical progression of new organic compounds with targeted biological activity (Q19981): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in 1 language: translated_label) |
(Removed claim: summary (P836): The objective of the project is to optimise and preclinical profiling of selected compounds with unique biological activity with the potential to exhibit therapeutic efficacy in minimal side effects in oncology and cardiology. The project will include, inter alia, the preparation of a broad diet of compounds and a thorough testing of biological and particularly pharmacological properties, including in vivo studies. The resulting intellectual p...) |
||
| Property / summary | |||
| Property / summary: The objective of the project is to optimise and preclinical profiling of selected compounds with unique biological activity with the potential to exhibit therapeutic efficacy in minimal side effects in oncology and cardiology. The project will include, inter alia, the preparation of a broad diet of compounds and a thorough testing of biological and particularly pharmacological properties, including in vivo studies. The resulting intellectual property will be thoroughly treated. The results (TRL3) will be finalised with application firmware. (English) / rank | |||
Revision as of 17:34, 22 October 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical progression of new organic compounds with targeted biological activity |
Project in Czech Republic financed by DG Regio |
Statements
92,429,398.75 Czech koruna
0 references
108,740,469.26 Czech koruna
0 references
85.0 percent
0 references
1 August 2018
0 references
31 December 2022
0 references
Masarykova univerzita
0 references
49°12'8.64"N, 16°36'28.44"E
0 references
49°11'55.68"N, 16°36'7.06"E
0 references
60200
0 references
Cílem projektu je optimalizace a preklinická profilace vybraných sloučenin s unikátní biologickou aktivitou s potenciálem vykázat terapeutickou účinnost při minimálních nežádoucích vedlejších účincích v oblasti onkologie a kardiologie. Náplní projektu bude mj. příprava širokého setu sloučenin a důkladné testování biologických a obzvláště farmakologických vlastností, včetně in vivo studií. Vzniklé duševní vlastnictví bude důsledně ošetřeno. Výsledky (TRL3)budou dopracovány s aplikačními firmami. a. (Czech)
0 references
Identifiers
CZ.02.1.01/0.0/0.0/16_025/0007381
0 references